Onxeo onxeo.com

Onxeo (Paris: ONXEO) is a developer of orphan oncology drugs. The company is focused on developing therapeutics for rare cancers, one of the fastest growing markets in the healthcare industry with high, unmet medical needs. Onxeo's comprehensive portfolio features a broad orphan oncology pipeline, with three independent programs in advanced clinical development, including Onxeo's first approved orphan oncology drug, Beleodaq.

Onxeo (Paris: ONXEO) is a developer of orphan oncology drugs. The company is focused on developing therapeutics for rare cancers, one of the fastest growing markets in the healthcare industry with high, unmet medical needs. Onxeo's comprehensive port...Show all

See All Exits Recent Exits

Phone: +33 (0)1 45 58 76 00

Fax:

49 boulevard du General Martial Valin

Paris, 75015
France

Onxeo - Investments & Acquisitions

Show Real Data Onxeo Investments
See all Recent Investments
Date Company Round Amount Co-investors
2016-02-29DNA TherapeuticsAcquired
2014-05-22TopotargetMerger
2014-05-22BioAlliance PharmaMerger
See all 3 investments